Filter
259
Text search:
molecular
markers
Featured
Recommendations
36
New Publications
54
Language
Document type
No document type
124
Guidelines
59
Studies & Reports
41
Manuals
16
Fact sheets
9
Strategic & Response Plan
4
Training Material
3
Situation Updates
2
Resource Platforms
1
Countries / Regions
India
32
Global
11
Africa
8
Kenya
7
Latin America and the Carribbean
7
South Africa
4
Tanzania
3
Brazil
3
Sierra Leone
2
Philippines
2
Pakistan
2
West and Central Africa
2
Venezuela
2
Liberia
1
Nigeria
1
Congo, Democratic Republic of
1
USA
1
Ethiopia
1
Cameroon
1
Uganda
1
Zimbabwe
1
Nepal
1
Afghanistan
1
Zambia
1
Syria
1
Malawi
1
Benin
1
Peru
1
South–East Asia Region
1
Western Pacific Region
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Georgia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
55
Public Health
23
Pharmacy & Technologies
14
Key Resources
5
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
34
TB
28
HIV
17
Mental Health
17
NTDs
16
AMR
14
NCDs
14
Rapid Response
12
Ebola
5
Refugee
4
Pharmacy
4
Planetary Health
3
Disability
2
Cholera
2
Specific Hazards
2
Polio
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
Accessed February 6, 2020
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
Accessed Febr. 6, 2020
In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed here, using a risk analysis framework. Some recommendations on responsible conduct in this context are pr
...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
Guidelines
HIV testing services
July 2015
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro
...
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec
...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is
...
Updated July 3, 2020
Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas
recommended
Short Version
This clinical practice guideline was developed in order to provide recommendations for the management of critically ill adult patients with COVID-19 in intensive care units (ICUs).
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
